HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patient selection for liver transplant: 1-year experience with 555 patients at a single center.

Abstract
Liver transplant (LT) has revolutionized the management of end-stage liver disease in the past 2 decades. The institution of the Model for End-Stage Liver Disease scoring system for organ allocation has de-emphasized recipient waiting time, but its effect on patients' referral to liver transplant centers is unclear. The aim of this retrospective study was to analyze the outcome of patients referred for liver transplant in a 12-month period (January 1, 2005, through December 31, 2005) after the institution of the new scoring system. During the study period, 555 patients were presented 605 times to the Liver Transplant Selection Committee. Of the 295 patients initially denied LT, 150 patients (51%) were denied because they were considered too early, 29 (10%) because their tumor did not meet institutional criteria, 72 (24%) because of concomitant psychosocial issues, and 44 (15%) because of comorbid conditions. Patients considered too early and those with psychosocial reasons for denial were often re-presented and listed for LT. Our findings suggest that patients could benefit from early referral to an LT center, even if they are initially denied listing, because management of end-stage renal disease could be initiated and psychosocial issues could be addressed. Referring physicians and transplant centers need to develop a strategy to ensure optimal timing of referrals for LT.
AuthorsJaime Aranda-Michel, Rolland C Dickson, Hugo Bonatti, John R Crossfield, Andrew P Keaveny, Adriana R Vasquez
JournalMayo Clinic proceedings (Mayo Clin Proc) Vol. 83 Issue 2 Pg. 165-8 (Feb 2008) ISSN: 0025-6196 [Print] England
PMID18241626 (Publication Type: Journal Article)
Topics
  • Cohort Studies
  • Databases, Factual
  • Humans
  • Liver Failure (surgery)
  • Liver Transplantation (statistics & numerical data)
  • Patient Selection
  • Referral and Consultation
  • Retrospective Studies
  • Time Factors
  • Tissue and Organ Procurement (organization & administration)
  • Treatment Outcome
  • Waiting Lists

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: